Completed OBSERVATIONAL NCT01427712

Special Investigation (All Cases) of LipaCreon in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Sponsor: Mylan Inc.

Conditions Cystic Fibrosis Digestive System Diseases Exocrine Pancreatic Insufficiency Pancreatic Diseases

Updated 9 times since 2017 Last updated: Mar 9, 2022 Started: Aug 31, 2011 Primary completion: Mar 31, 2018 Completion: Mar 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cystic Fibrosis and Digestive System Diseases and is currently completed. Mylan Inc. leads this study, which shows 9 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

9 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jul 2022 — Jul 2024 [monthly]

Completed

Status: Unknown Status → Completed
Jan 2021 — Jul 2022 [monthly]

Unknown Status

▶ Show 4 earlier versions

Nov 2018 — Jan 2021 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jun 2018 — Nov 2018 [monthly]

Recruiting
Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Aug 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mylan Inc.

Data source: Viatris Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aichi, Japan , Ehime, Japan , Hyōgo, Japan , Ibaraki, Japan , Ishikawa, Japan , Kagawa, Japan , Kagoshima, Japan , Kanagawa, Japan , Miyagi, Japan , Osaka, Japan and 4 more locations